Author Page for Yan-Chang Xu

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Three-Year Outcomes of Perioperative Camrelizumab Plus Apatinib Combined with Chemotherapy Versus Apatinib Plus Chemotherapy and Chemotherapy Alone in Neoadjuvant Treatment for Locally Advanced Gastric Cancer: A Nonrandomized Controlled Trial

Number of pages: 34 Posted: 16 Apr 2026

Ze-Ning Huang, Wenwu Qiu, Yan-Chang Xu, Ping Li and See PDF

Fujian Medical University, Fujian Medical University - Department of Gastric Surgery, Fujian Medical University, Fujian Medical University - Department of Gastric Surgery and Please see PDF for full list of authors & affiliations

Downloads 30 (1,385,945)

View PDF
Download

Yan-Chang Xu

Fujian Medical University

1

30

0

Scholarly Papers (1)

Three-Year Outcomes of Perioperative Camrelizumab Plus Apatinib Combined with Chemotherapy Versus Apatinib Plus Chemotherapy and Chemotherapy Alone in Neoadjuvant Treatment for Locally Advanced Gastric Cancer: A Nonrandomized Controlled Trial

Abstract: